These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 17519455)
1. Managing wholesaler agreements in the fee-for-service era. Fein AJ Am J Health Syst Pharm; 2007 Jun; 64(11):1153-4. PubMed ID: 17519455 [No Abstract] [Full Text] [Related]
2. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists. Kirschenbaum BE Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075 [TBL] [Abstract][Full Text] [Related]
3. Evaluating group purchasing through a prime vendor. Johnson LH; Herrick JD Am J Hosp Pharm; 1984 Sep; 41(9):1783-8. PubMed ID: 6437220 [TBL] [Abstract][Full Text] [Related]
5. The role of the pharmaceutical wholesaler in hospital purchasing group contracts. Bobbitt RA Top Hosp Pharm Manage; 1987 Aug; 7(2):22-32. PubMed ID: 10314236 [No Abstract] [Full Text] [Related]
6. Negotiating innovative relationships with pharmaceutical companies: the pharmaceutical industry's perspective. Evans RT Am J Health Syst Pharm; 1996 Feb; 53(4 Suppl 1):S37-9. PubMed ID: 8673677 [No Abstract] [Full Text] [Related]
7. Negotiating innovative relationships with pharmaceutical companies: integrated health systems' perspective. Clark DL Am J Health Syst Pharm; 1996 Feb; 53(4 Suppl 1):S39-41. PubMed ID: 8673678 [No Abstract] [Full Text] [Related]
9. Electronic data interchange for pharmacy inventory control. Neal TA; Whiteman J; Swenson JP Am J Hosp Pharm; 1990 Nov; 47(11):2483-7. PubMed ID: 2278259 [TBL] [Abstract][Full Text] [Related]
10. Generic drug prices fall 7%-24%; groups sort out manufacturers. Bernstein T Hosp Mater Manage; 1989 Feb; 14(2):8-10. PubMed ID: 10318186 [No Abstract] [Full Text] [Related]
11. A drug recall procedure for Canadian hospitals. Gibson C Can J Hosp Pharm; 1979; 32(2):45-6. PubMed ID: 10316819 [No Abstract] [Full Text] [Related]
12. Pharmaceutical Spending in Fee-for-Service Medicare: Looking Ahead to the Inflation Reduction Act. Gellad WF; Hernandez I JAMA; 2022 Oct; 328(15):1502-1503. PubMed ID: 36255438 [No Abstract] [Full Text] [Related]
13. Hospital pharmacists' evaluation of drug wholesaler services. Allen WO; Ryan MR; Roberts KB Am J Hosp Pharm; 1983 Oct; 40(10):1658-61. PubMed ID: 6638028 [TBL] [Abstract][Full Text] [Related]
14. [Pharmaceutical distribution and retail pharmacy]. Meneu R Gac Sanit; 2006 Mar; 20 Suppl 1():154-9. PubMed ID: 16539978 [TBL] [Abstract][Full Text] [Related]
15. ASHP guidelines on managing drug product shortages. Fox ER; McLaughlin MM Am J Health Syst Pharm; 2018 Nov; 75(21):1742-1750. PubMed ID: 30061155 [No Abstract] [Full Text] [Related]
16. Expenses for meetings and fees for service: details of 'disclosure' required of pharmaceutical companies. Shurlock B Eur Heart J; 2013 Dec; 34(47):3589-90. PubMed ID: 24335158 [No Abstract] [Full Text] [Related]